NEW YORK, April 9, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced its intention to offer shares of common stock through...
Read More Details
Finally We wish PressBee provided you with enough information of ( Lucid Diagnostics Announces Proposed Public Offering of Common Stock )
Also on site :